[go: up one dir, main page]

SE0302666D0 - Novel Compounds - Google Patents

Novel Compounds

Info

Publication number
SE0302666D0
SE0302666D0 SE0302666A SE0302666A SE0302666D0 SE 0302666 D0 SE0302666 D0 SE 0302666D0 SE 0302666 A SE0302666 A SE 0302666A SE 0302666 A SE0302666 A SE 0302666A SE 0302666 D0 SE0302666 D0 SE 0302666D0
Authority
SE
Sweden
Prior art keywords
novel compounds
formula
compounds
prophylaxis
atherosclerosis
Prior art date
Application number
SE0302666A
Other languages
English (en)
Inventor
Gunnar Nordvall
Tobias Rein
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302666A priority Critical patent/SE0302666D0/sv
Publication of SE0302666D0 publication Critical patent/SE0302666D0/sv
Priority to US10/575,534 priority patent/US20070142386A1/en
Priority to KR1020067006638A priority patent/KR20060120014A/ko
Priority to CA002541533A priority patent/CA2541533A1/en
Priority to AU2004278276A priority patent/AU2004278276B2/en
Priority to PCT/SE2004/001421 priority patent/WO2005033115A1/en
Priority to JP2006532235A priority patent/JP2007507494A/ja
Priority to MXPA06003792A priority patent/MXPA06003792A/es
Priority to BRPI0415050-3A priority patent/BRPI0415050A/pt
Priority to EP04775512A priority patent/EP1675862A1/en
Priority to CN 200480027529 priority patent/CN1856499A/zh
Priority to IL174508A priority patent/IL174508A0/en
Priority to NO20062061A priority patent/NO20062061L/no

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0302666A 2003-10-07 2003-10-07 Novel Compounds SE0302666D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0302666A SE0302666D0 (sv) 2003-10-07 2003-10-07 Novel Compounds
CN 200480027529 CN1856499A (zh) 2003-10-07 2004-10-05 用作趋化因子受体尤其是cx3cr1拮抗剂的新的2－取代的4－氨基－噻唑并[4,5－d]嘧啶
AU2004278276A AU2004278276B2 (en) 2003-10-07 2004-10-05 New 2-substituted, 4-amino-thiazolo(4,5-d) pyrimidines, useful as chemokine receptor antagonists, esp. CX3CR1
KR1020067006638A KR20060120014A (ko) 2003-10-07 2004-10-05 케모킨, 특히 ｃｘ3ｃｒ1 수용체 길항제로서 유용한 신규한2-치환된 4-아미노-티아졸로[4,5-ｄ]피리미딘
CA002541533A CA2541533A1 (en) 2003-10-07 2004-10-05 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
US10/575,534 US20070142386A1 (en) 2003-10-07 2004-10-05 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
PCT/SE2004/001421 WO2005033115A1 (en) 2003-10-07 2004-10-05 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
JP2006532235A JP2007507494A (ja) 2003-10-07 2004-10-05 ケモカイン受容体アンタゴニストとりわけＣＸ３ＣＲ１として有用な新規な２−置換４−アミノ−チアゾロ［４，５−ｄ］ピリミジン
MXPA06003792A MXPA06003792A (es) 2003-10-07 2004-10-05 Nuevas 4-amino-tiazolo[4,5-d]-pirimidinas 2-sustituidas, utiles como antagonistas del receptor de quimiocina, especialmente cx3cr1.
BRPI0415050-3A BRPI0415050A (pt) 2003-10-07 2004-10-05 composto, formulação farmacêutica, método para tratar ou reduzir risco de uma doença ou condição humanas, uso de um composto ou de um sal deste farmaceuticamente aceitável, e, processo para a preparação de um composto ou de um sal deste farmaceuticamente aceitável
EP04775512A EP1675862A1 (en) 2003-10-07 2004-10-05 New 2-substituted, 4-amino-thiazolo 4,5-d pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
IL174508A IL174508A0 (en) 2003-10-07 2006-03-23 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
NO20062061A NO20062061L (no) 2003-10-07 2006-05-08 Nye substituerte, 4-amino-tiazolo[4,5-D]pyriminder, nyttige som kjemokinreseptorantagonister, ESP. CX3CR1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302666A SE0302666D0 (sv) 2003-10-07 2003-10-07 Novel Compounds

Publications (1)

Publication Number Publication Date
SE0302666D0 true SE0302666D0 (sv) 2003-10-07

Family

ID=29398688

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302666A SE0302666D0 (sv) 2003-10-07 2003-10-07 Novel Compounds

Country Status (2)

Country Link
CN (1) CN1856499A (sv)
SE (1) SE0302666D0 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014142056A1 (ja) * 2013-03-12 2014-09-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピロリジン－３－イル酢酸誘導体の塩およびその結晶
CN104195234A (zh) * 2014-07-29 2014-12-10 杭州艾迪康医学检验中心有限公司 检测cx3cr1基因v249i突变位点的方法和引物

Also Published As

Publication number Publication date
CN1856499A (zh) 2006-11-01

Similar Documents

Publication Publication Date Title
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
GEP20084527B (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
WO2005056524A3 (en) Therapeutic agents useful for treating pain
AP1818A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
NO20062061L (no) Nye substituerte, 4-amino-tiazolo[4,5-D]pyriminder, nyttige som kjemokinreseptorantagonister, ESP. CX3CR1
DE602004024375D1 (de) Carboxamidderivate
WO2003048164A3 (en) Adenosine a2a receptor antagonists
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
CY1114803T1 (el) Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης
EA200401114A2 (ru) Замещённые гидроксиэтиламины
SE0401342D0 (sv) Therapeutic compounds
MY169274A (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
UA92181C2 (ru) Производные пиримидина и их применение в терапии и в производстве лекарственного средства для предотвращения и/или лечения болезни альцгеймера
TW200505823A (en) CaSR antagonist
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
MX2008001606A (es) Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico.
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
MX2008012093A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos.
ATE370147T1 (de) Thiazolopyrimidinderivate und deren verwendung als antagonisten des cx3cr1 rezeptors